HUP0301749A2 - Acilfenil-karbamid-származékok, eljárás az elżállításukra és gyógyszerkénti alkalmazásuk - Google Patents
Acilfenil-karbamid-származékok, eljárás az elżállításukra és gyógyszerkénti alkalmazásuk Download PDFInfo
- Publication number
- HUP0301749A2 HUP0301749A2 HU0301749A HUP0301749A HUP0301749A2 HU P0301749 A2 HUP0301749 A2 HU P0301749A2 HU 0301749 A HU0301749 A HU 0301749A HU P0301749 A HUP0301749 A HU P0301749A HU P0301749 A2 HUP0301749 A2 HU P0301749A2
- Authority
- HU
- Hungary
- Prior art keywords
- alkyl
- alkylene
- group
- coo
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
- C07C275/48—Y being a hydrogen or a carbon atom
- C07C275/54—Y being a carbon atom of a six-membered aromatic ring, e.g. benzoylureas
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10028175 | 2000-06-09 | ||
| DE2001116768 DE10116768A1 (de) | 2001-04-04 | 2001-04-04 | Acylphenylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PCT/EP2001/006030 WO2001094300A1 (de) | 2000-06-09 | 2001-05-26 | Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0301749A2 true HUP0301749A2 (hu) | 2003-09-29 |
Family
ID=26005991
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0301749A HUP0301749A2 (hu) | 2000-06-09 | 2001-05-26 | Acilfenil-karbamid-származékok, eljárás az elżállításukra és gyógyszerkénti alkalmazásuk |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6506778B2 (enExample) |
| EP (1) | EP1294682B1 (enExample) |
| JP (1) | JP4510372B2 (enExample) |
| KR (1) | KR20030007934A (enExample) |
| CN (1) | CN1280266C (enExample) |
| AR (1) | AR030230A1 (enExample) |
| AT (1) | ATE265424T1 (enExample) |
| AU (2) | AU6231801A (enExample) |
| BR (1) | BR0111457A (enExample) |
| CA (1) | CA2411082A1 (enExample) |
| CZ (1) | CZ20024003A3 (enExample) |
| DE (1) | DE50102147D1 (enExample) |
| DK (1) | DK1294682T3 (enExample) |
| EE (1) | EE200200634A (enExample) |
| ES (1) | ES2215902T3 (enExample) |
| HR (1) | HRP20020968A2 (enExample) |
| HU (1) | HUP0301749A2 (enExample) |
| IL (1) | IL153273A0 (enExample) |
| MX (1) | MXPA02011458A (enExample) |
| NO (1) | NO20025879L (enExample) |
| NZ (1) | NZ523034A (enExample) |
| PL (1) | PL359178A1 (enExample) |
| PT (1) | PT1294682E (enExample) |
| SK (1) | SK17252002A3 (enExample) |
| TR (1) | TR200401029T4 (enExample) |
| WO (1) | WO2001094300A1 (enExample) |
| YU (1) | YU91002A (enExample) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20021091A1 (es) * | 2001-05-25 | 2003-02-04 | Aventis Pharma Gmbh | Derivados de fenilurea sustituidos con carbonamida y procedimiento para su preparacion |
| DE10125567B4 (de) * | 2001-05-25 | 2004-08-26 | Aventis Pharma Deutschland Gmbh | Carbonamid substituierte Phenylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE10139416A1 (de) * | 2001-08-17 | 2003-03-06 | Aventis Pharma Gmbh | Aminoalkyl substituierte aromatische Bicyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| GB0205165D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205176D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205175D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205170D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205162D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| GB0205166D0 (en) | 2002-03-06 | 2002-04-17 | Astrazeneca Ab | Chemical compounds |
| US7078404B2 (en) | 2002-04-11 | 2006-07-18 | Sanofi-Aventis Deutschland Gmbh | Acyl-3-carboxyphenylurea derivatives, processes for preparing them and their use |
| DE10215907A1 (de) * | 2002-04-11 | 2003-11-06 | Aventis Pharma Gmbh | Acyl-4-carboxyphenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung |
| DE10215908B4 (de) * | 2002-04-11 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Acyl-3-carboxyphenyl-harnstoffderivate und deren Verwendung als Arzneimittel |
| US7223796B2 (en) | 2002-04-11 | 2007-05-29 | Sanofi-Aventis Deutschland Gmbh | Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use |
| US7049341B2 (en) | 2002-06-07 | 2006-05-23 | Aventis Pharma Deutschland Gmbh | N-benzoylureidocinnamic acid derivatives, processes for preparing them and their use |
| DE10225635C1 (de) * | 2002-06-07 | 2003-12-24 | Aventis Pharma Gmbh | N-Benzoylureido-Zimtsäurederivate, Verfahren zu deren Herstellung und deren Verwendung |
| US7262220B2 (en) | 2002-07-11 | 2007-08-28 | Sanofi-Aventis Deutschland Gmbh | Urea- and urethane-substituted acylureas, process for their preparation and their use |
| DE50311923D1 (de) * | 2002-07-11 | 2009-10-29 | Sanofi Aventis Deutschland | Harnstoff- und urethan-substituierte acylharnstoffe, verfahren zu deren herstellung und deren verwendung als arzneimittel |
| AU2003249937A1 (en) * | 2002-07-12 | 2004-02-02 | Sanofi-Aventis Deutschland Gmbh | Heterocyclically substituted benzoylureas, method for their production and their use as medicaments |
| DE10231627B4 (de) * | 2002-07-12 | 2006-03-09 | Sanofi-Aventis Deutschland Gmbh | Heterozyklisch substituierte Benzoylharnstoffe und ihre Verwendung als Arzneimittel |
| DE10246434B4 (de) * | 2002-10-04 | 2005-08-04 | Aventis Pharma Deutschland Gmbh | Carboxyalkoxy-substituierte Acyl-carboxyphenyl-harnstoffderivate und ihre Verwendung als Arzneimittel |
| US20040157922A1 (en) | 2002-10-04 | 2004-08-12 | Aventis Pharma Deutschland Gmbh | Carboxyalkoxy-substituted acyl-carboxyphenylurea derivatives and their use as medicaments |
| US7179941B2 (en) * | 2003-01-23 | 2007-02-20 | Sanofi-Aventis Deutschland Gmbh | Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use |
| DE10302452B4 (de) * | 2003-01-23 | 2005-02-24 | Aventis Pharma Deutschland Gmbh | Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung |
| DE10306502B4 (de) * | 2003-02-17 | 2005-03-17 | Aventis Pharma Deutschland Gmbh | Substituierte 3-(Benzoylureido)-thiophenderivate und sie enthaltende Arzneimittel |
| US7196114B2 (en) * | 2003-02-17 | 2007-03-27 | Sanofi-Aventis Deutschland Gmbh | Substituted 3-(benzoylureido) thiophene derivatives, processes for preparing them and their use |
| DE10308351A1 (de) * | 2003-02-27 | 2004-11-25 | Aventis Pharma Deutschland Gmbh | 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE10308355A1 (de) * | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
| DE10308352A1 (de) | 2003-02-27 | 2004-09-09 | Aventis Pharma Deutschland Gmbh | Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
| US7148246B2 (en) | 2003-02-27 | 2006-12-12 | Sanofi-Aventis Deutschland Gmbh | Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
| DE10308353A1 (de) | 2003-02-27 | 2004-12-02 | Aventis Pharma Deutschland Gmbh | Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE10309929B4 (de) * | 2003-03-07 | 2006-02-23 | Sanofi-Aventis Deutschland Gmbh | Substituierte Benzoylureidopyridyl-piperidin- und -pyrrolidin-carbonsäurederivate, Verfahren zu deren Herstellung und deren Verwendung |
| US7501440B2 (en) | 2003-03-07 | 2009-03-10 | Sanofi-Aventis Deutschland Gmbh | Substituted benzoylureidopyridylpiperidine-and-pyrrolidinecarboxylic acid derivatives, processes for preparing them and their use |
| DE10335092B3 (de) | 2003-08-01 | 2005-02-03 | Aventis Pharma Deutschland Gmbh | Substituierte Benzoylureido-o-benzoylamide, Verfahren zu deren Herstellung und deren Verwendung |
| US7241787B2 (en) | 2004-01-25 | 2007-07-10 | Sanofi-Aventis Deutschland Gmbh | Substituted N-cycloexylimidazolinones, process for their preparation and their use as medicaments |
| EP1586573B1 (en) | 2004-04-01 | 2007-02-07 | Sanofi-Aventis Deutschland GmbH | Oxadiazolones, processes for their preparation and their use as pharmaceuticals |
| US7963448B2 (en) * | 2004-12-22 | 2011-06-21 | Cognex Technology And Investment Corporation | Hand held machine vision method and apparatus |
| JP2008536932A (ja) * | 2005-04-18 | 2008-09-11 | サイード・アール・カーン | チューブリン重合阻害剤：ボンゾイルフェニル尿素（ｂｐｕ）硫黄類似体の設計及び合成 |
| BRPI0609464A2 (pt) * | 2005-05-23 | 2010-04-13 | Japan Tobacco Inc | composto de pirazol e agente terapêutico para diabetes compreendendo o mesmo |
| DE102005026762A1 (de) | 2005-06-09 | 2006-12-21 | Sanofi-Aventis Deutschland Gmbh | Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| EP2096111A1 (en) * | 2006-11-20 | 2009-09-02 | Japan Tobacco Inc. | Pyrazoles and use thereof as drugs |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| PL3004138T3 (pl) | 2013-06-05 | 2024-07-29 | Bausch Health Ireland Limited | Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie |
| BR112017003745A2 (pt) | 2014-08-29 | 2017-12-05 | Tes Pharma S R L | inibidores de semialdeído descarboxilase de ácido alfa-amino-beta-carboximucônico |
| AU2017342083A1 (en) | 2016-10-14 | 2019-04-11 | Tes Pharma S.R.L. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
| EP3883930A1 (en) | 2018-11-20 | 2021-09-29 | Tes Pharma S.r.l. | Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase |
| CN117603095B (zh) * | 2023-11-24 | 2025-08-29 | 中国烟草云南进出口有限公司 | 灭幼脲半抗原、抗原、抗体、检测装置及其制备和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH516578A (de) * | 1967-11-02 | 1971-12-15 | Bayer Ag | Verfahren zur Herstellung von heterocyclische Acylaminogruppen enthaltenden Arylsulfonylharnstoffen mit blutdrucksenkender Wirkung |
| ZA793186B (en) * | 1978-07-06 | 1981-02-25 | Duphar Int Res | New urea and thiourea compounds, method of preparing the new compounds, as well as insecticidal compositions on the basis of these compounds |
| ATE43788T1 (de) * | 1983-09-01 | 1989-06-15 | Duphar Int Res | Benzoylharnstoffe mit antitumoraler wirkung. |
| JPS60237056A (ja) * | 1984-05-08 | 1985-11-25 | Ishihara Sangyo Kaisha Ltd | Ｎ−ベンゾイル−ｎ′−フエニルウレア系化合物及びそれらを含有する殺虫剤 |
| EP0167197B1 (en) * | 1984-07-05 | 1989-01-18 | Duphar International Research B.V | Benzoylurea compounds, and insecticidal and acaricidal compositions comprising same |
| DE3504749A1 (de) * | 1985-02-08 | 1986-08-14 | Schering AG, 1000 Berlin und 4709 Bergkamen | Acylharnstoffe, insektizide mittel enthaltend diese verbindungen sowie verfahren zu ihrer herstellung |
| JPH0791248B2 (ja) * | 1988-06-29 | 1995-10-04 | 富士写真フイルム株式会社 | アルコキシもしくはアリールオキシベンゼン化合物の製造方法 |
| DE4208778C1 (enExample) * | 1992-03-17 | 1993-09-23 | Schering Ag Berlin Und Bergkamen, 13353 Berlin, De | |
| GB9313268D0 (en) * | 1993-06-28 | 1993-08-11 | Zeneca Ltd | Chemical compounds |
-
2001
- 2001-05-26 AU AU6231801A patent/AU6231801A/xx active Pending
- 2001-05-26 IL IL15327301A patent/IL153273A0/xx unknown
- 2001-05-26 JP JP2002501817A patent/JP4510372B2/ja not_active Expired - Fee Related
- 2001-05-26 MX MXPA02011458A patent/MXPA02011458A/es active IP Right Grant
- 2001-05-26 DE DE50102147T patent/DE50102147D1/de not_active Expired - Lifetime
- 2001-05-26 CA CA002411082A patent/CA2411082A1/en not_active Abandoned
- 2001-05-26 EP EP01936399A patent/EP1294682B1/de not_active Expired - Lifetime
- 2001-05-26 CZ CZ20024003A patent/CZ20024003A3/cs unknown
- 2001-05-26 CN CNB018108016A patent/CN1280266C/zh not_active Expired - Fee Related
- 2001-05-26 HU HU0301749A patent/HUP0301749A2/hu unknown
- 2001-05-26 ES ES01936399T patent/ES2215902T3/es not_active Expired - Lifetime
- 2001-05-26 DK DK01936399T patent/DK1294682T3/da active
- 2001-05-26 BR BR0111457-3A patent/BR0111457A/pt not_active IP Right Cessation
- 2001-05-26 WO PCT/EP2001/006030 patent/WO2001094300A1/de not_active Ceased
- 2001-05-26 AU AU2001262318A patent/AU2001262318B2/en not_active Ceased
- 2001-05-26 NZ NZ523034A patent/NZ523034A/en unknown
- 2001-05-26 EE EEP200200634A patent/EE200200634A/xx unknown
- 2001-05-26 KR KR1020027016791A patent/KR20030007934A/ko not_active Ceased
- 2001-05-26 AT AT01936399T patent/ATE265424T1/de not_active IP Right Cessation
- 2001-05-26 TR TR2004/01029T patent/TR200401029T4/xx unknown
- 2001-05-26 YU YU91002A patent/YU91002A/sh unknown
- 2001-05-26 PL PL01359178A patent/PL359178A1/xx not_active Application Discontinuation
- 2001-05-26 PT PT01936399T patent/PT1294682E/pt unknown
- 2001-05-26 SK SK1725-2002A patent/SK17252002A3/sk unknown
- 2001-05-26 HR HR20020968A patent/HRP20020968A2/xx not_active Application Discontinuation
- 2001-06-07 AR ARP010102735A patent/AR030230A1/es unknown
- 2001-06-08 US US09/875,901 patent/US6506778B2/en not_active Expired - Lifetime
-
2002
- 2002-12-06 NO NO20025879A patent/NO20025879L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR0111457A (pt) | 2003-06-24 |
| HRP20020968A2 (en) | 2005-02-28 |
| NO20025879D0 (no) | 2002-12-06 |
| AR030230A1 (es) | 2003-08-13 |
| ATE265424T1 (de) | 2004-05-15 |
| JP2003535843A (ja) | 2003-12-02 |
| IL153273A0 (en) | 2003-07-06 |
| CN1280266C (zh) | 2006-10-18 |
| CN1434796A (zh) | 2003-08-06 |
| JP4510372B2 (ja) | 2010-07-21 |
| DK1294682T3 (da) | 2004-08-02 |
| AU6231801A (en) | 2001-12-17 |
| EE200200634A (et) | 2004-04-15 |
| HK1056715A1 (en) | 2004-02-27 |
| SK17252002A3 (sk) | 2003-05-02 |
| WO2001094300A1 (de) | 2001-12-13 |
| DE50102147D1 (de) | 2004-06-03 |
| CZ20024003A3 (cs) | 2003-03-12 |
| PT1294682E (pt) | 2004-09-30 |
| US20020151586A1 (en) | 2002-10-17 |
| US6506778B2 (en) | 2003-01-14 |
| NZ523034A (en) | 2004-07-30 |
| MXPA02011458A (es) | 2003-04-25 |
| NO20025879L (no) | 2003-01-29 |
| ES2215902T3 (es) | 2004-10-16 |
| YU91002A (sh) | 2006-05-25 |
| TR200401029T4 (tr) | 2004-06-21 |
| AU2001262318B2 (en) | 2005-09-08 |
| EP1294682A1 (de) | 2003-03-26 |
| PL359178A1 (en) | 2004-08-23 |
| CA2411082A1 (en) | 2002-12-05 |
| EP1294682B1 (de) | 2004-04-28 |
| KR20030007934A (ko) | 2003-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4510372B2 (ja) | アシルフェニル尿素誘導体、その製造方法及び医薬としてのその使用 | |
| TW202341983A (zh) | 用於降解突變kras蛋白之化合物及其應用 | |
| KR100837420B1 (ko) | 5-히드록시-인돌-3-카르복시산에스테르 유도체 및 이의용도 | |
| KR20040003007A (ko) | 카복스아미드 치환된 페닐우레아 유도체 및 약물로서의이의 제조방법 | |
| KR20150084974A (ko) | 피롤 설폰아미드 유도체, 이의 제조 방법, 및 이의 의학적 적용 | |
| JP2022169800A (ja) | 細菌の排出ポンプ阻害剤 | |
| EP3677584A1 (en) | Compound having bruton's tyrosine kinase (btk)-inhibition and degradation activity | |
| EP4163272A1 (en) | Benzothiazole derivative and application thereof | |
| CA2986930A1 (en) | Chemical modulators of signaling pathways and therapeutic use | |
| JP2022548250A (ja) | 甲状腺ホルモン受容体ベータアゴニスト化合物 | |
| EP3838901B1 (en) | Compound for treatment of rabies and method for treatment of rabies | |
| JP2013532657A (ja) | 環式ｎ，ｎ’−ジアリールチオ尿素及びｎ，ｎ’−ジアリール尿素−アンドロゲン受容体アンタゴニスト、抗癌剤、その調製のための方法及び使用 | |
| JP2020525409A (ja) | 置換アリールエーテル系化合物、その調製方法、医薬組成物およびその応用 | |
| CN115003650B (zh) | 二取代金刚烷基衍生物、其药学上可接受的盐及包含其作为有效成分的用于抑制癌生长的药物组合物 | |
| ES2494765T3 (es) | Compuestos y métodos para inhibir la interacción de proteínas BLC con compañeros de unión | |
| EP3447045B1 (en) | 1-(1-hydroxy-2,3-dihydro-1h-inden-5-yl)-urea derivatives and related compounds kcnq 2-5 channel activators for treating dysuria | |
| JP5330377B2 (ja) | ３，４−ジヒドロキナゾリン誘導体 | |
| SK2722002A3 (en) | Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia | |
| KR20180020119A (ko) | 새로운 5형포스포디에스테라아제 억제제 및 그 용도 | |
| CN113387909A (zh) | 2,3-环氧丁二酰衍生物的医药用途 | |
| KR102421065B1 (ko) | 새로운 퀴논-인돌리진 하이브리드 유도체 제조방법 및 이를 포함하는 항암제 조성물 | |
| EP4506346A1 (en) | Thiobenzimidazole derivative or pharmaceutically acceptable salt thereof, and use thereof | |
| WO2010103067A1 (en) | Pharmaceutical combination of 5-fluorouracil and derivate of 1,4-dihydropyridine and its use in the treatment of cancer | |
| RU2271350C2 (ru) | Производные ацилфенилмочевины, фармацевтическая композиция и способ ее получения | |
| KR20150051016A (ko) | 구아니딘 화합물 및 이의 용도 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |